Home / Stocks / BLSM

BLSM insider trading

BlossomHill Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
6
Bought · 24 mo
$25.2M
Buys · last 90 days
6 · $25.2M
Most recent buy
2026-08-12

Cluster buy detected

6 insiders bought BLSM within a short window (2026-08-07→2026-08-10), $25.2M in total — cluster score 67/100. Members see the buyers, the score breakdown and the chart.

See the cluster

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-08-12ORBIMED ADVISORS LLCcluster
Director
Bought625,000$16.00$10.0M
2026-08-12GORDON CARL Lcluster
Director
Bought625,000$16.00$10.0M
2026-08-10Liptak Vincent Paulcluster
General Counsel
Bought4,700$15.89$75k
2026-08-10Chen Bihuacluster
Director · 10% owner
Bought312,500$16.00$5.0M
2026-08-10Schmid John P.cluster
Director
Bought6,000$16.00$96k
2026-08-10Keyes Jason Acluster
Chief Financial Officer
Bought700$16.00$11k

Most active insider buyers

InsiderRoleBuysTotal bought
ORBIMED ADVISORS LLCDirector1$10.0M
GORDON CARL LDirector1$10.0M
Chen BihuaDirector · 10% owner1$5.0M
Schmid John P.Director1$96k
Liptak Vincent PaulGeneral Counsel1$75k
Keyes Jason AChief Financial Officer1$11k

See BLSM on the chart

Every insider buy and sell for BLSM plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.